Results 11 to 20 of about 15,778 (214)
Chemotherapy management of a pediatric B-ALL patient with moyamoya disease: a case report [PDF]
Frontiers in OncologyMoyamoya disease is a rare, chronic cerebrovascular disorder characterized by progressive stenosis or occlusion of the terminal portions of the internal carotid arteries and the subsequent development of abnormal compensatory vascular networks.
Yi-ren Cheng +4 more
doaj +2 more sources
QJM, 2016 Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease characterized by progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain. Although its etiology is unknown, recent genetic studies have identified RNF213 in the 17q25-ter region as an important ...
M, Tahir, U, Khan
+10 more sources
Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
Frontiers in Neurology, 2021 Objective: To determine if elevated rates of autoimmune disease are present in children with both Down syndrome and moyamoya disease given the high rates of autoimmune disease reported in both conditions and unknown etiology of angiopathy in this ...
Jonathan D. Santoro +17 more
doaj +1 more source
Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version
Neurologia Medico-Chirurgica, 2022 In this report, we, the Research Committee on Moyamoya Disease (Spontaneous Occlusion of the circle of Willis), describe in detail the changes in the new “Diagnostic Criteria 2021” for moyamoya disease and its scientific basis to make it widely known to ...
Satoshi KURODA +8 more
doaj +1 more source
Neuropathology, 2000 Moyamoya disease is a specific chronic cerebrovascular occlusive disease first reported by Japanese surgeons in 1957. The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion. It may cause ischemic attacks or cerebral
M, Fukui +3 more
openaire +4 more sources
Clinical value of the systemic immune-inflammation index in moyamoya disease
Frontiers in Neurology, 2023 BackgroundMoyamoya disease (MMD) is a rare cerebrovascular disorder with unknown etiology. The underlying pathophysiological mechanism of moyamoya disease remains to be elucidated, but recent studies have increasingly highlighted that abnormal immune ...
Erheng Liu +15 more
doaj +1 more source
Research progress of moyamoya disease combined with renovascular hypertension
Frontiers in Surgery, 2022 Moyamoya disease (MMD) is an idiopathic cerebrovascular disease which was first described by Suzuki and Takaku in 1969. Moyamoya disease is a non-atherosclerotic cerebrovascular structural disorder.
Erheng Liu +9 more
doaj +1 more source
BMC Pregnancy and Childbirth, 2022 Background Physiologic changes during pregnancy affect the development of postpartum cerebrovascular disease (CVD) in women with Moyamoya disease. Due to the rare prevalence of Moyamoya disease and its large regional variations, large-scale based studies
Yeonseong Jeong +7 more
doaj +1 more source
Stroke: Vascular and Interventional Neurology, 2023 Introduction Moyamoya disease was first described in the 1950’s. After over six decades, however, the underlying etiology of Moyamoya still remains unknown.
Nolan Brown +7 more
doaj +1 more source
Genetics and Biomarkers of Moyamoya Disease: Significance of as a Susceptibility Gene [PDF]
Journal of Stroke, 2014 Moyamoya disease is characterized by a progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain.
Miki Fujimura +6 more
doaj +1 more source